Overview
This laboratory has been conducting research on blood cancer generation, progression, and treatment methods using molecular biological techniques for the past 10 years. Translational research are being conducted by using mesenchymal stem cells (MSCs) are separated from the patient's bone marrow to identify hematological malignancies generation mechanisms, tumor microenvironment, and biomarkers with various experimental techniques. Students and researchers in master's and doctoral graduate programs are conducting joint research in cooperation with external institutions and leading pharmaceutical companies, and are actively researching to create clinical grounds for application to patient treatment.
(1) Identify the role and mechanism of MSC in the bone marrow to increase the efficiency of hematopoietic stem cell transplantation in hematologic malignancy patients.
(2) A Study on the effects and mechanism of female hormones in the diagnosis and Treatment of Female Hormones.
(3) A clinical study for the treatment of graft-versus-host disease by using mesenchymal stem cells.
In this laboratory, molecular biological mechanisms involved in the occurrence and recurrence of hematologic malignancies and treatment are identified as the basis of translational research. In addition, the goal is to discover biomarkers that can predict treatment response and increase treatment efficiency of patients, and to increase treatment effectiveness through personalized medical approach.